Stock Analiz

IQV vs CRL stock comparison

Iqvia vs. Charles River Laboratories International · data as of November 13, 2026

Iqvia (IQV) has a market value of about $43.7B, Charles River Laboratories International (CRL) about $16.2B. Over their latest twelve months Iqvia had revenue of $17.3B and Charles River Laboratories International $4.0B.

On our five checks Iqvia scores higher: 1.6 out of 5 (weak) against 1.2 (weak).

By area, the stronger company is Iqvia on value; Charles River Laboratories International on future growth; Iqvia on track record; Charles River Laboratories International on financial health.

Iqvia is cheaper on earnings (P/E 32.3 vs. 367.4).

Iqvia leads on 17 of the compared lines and Charles River Laboratories International on 3.

Side by side

IQVCRL
Size and price
Market cap$43.7B$16.2B
Share price$265.12$337.97
Score
Overall score (of 5)1.61.2
Value10
Future growth01
Track record30
Financial health12
Shareholder returns33
Valuation
P/E (TTM)32.3367.4
Forward P/E19.226.7
Price / free cash flow21.040.5
Price / sales2.54.1
EV / EBITDA16.842.4
PEG0.80—
DCF value vs. price−24%−76%
Business
Revenue$17.3B$4.0B
Net income$1.4B$40M
Free cash flow$2.1B$400M
Net margin8.1%1.0%
Gross margin (5-yr avg.)——
ROIC (5-yr avg.)8.0%5.6%
Growth
Revenue growth (1 yr)5.9%-0.9%
Revenue growth (5 yrs, per year)7.5%6.6%
EPS growth (5 yrs, per year)40.5%—
Balance sheet and payouts
Net cash (cash minus debt)-$14.0B-$2.7B
Dividend yieldNoneNone
Shareholder yield2.9%2.2%
Analysts
Upside to average target+18%+4%
Consensus ratingStrong buyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: IQV TTM to September 30, 2026, CRL TTM to September 26, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Iqvia or Charles River Laboratories International?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Iqvia scores 1.6 out of 5 and Charles River Laboratories International 1.2; the table shows where each one is stronger.

Is Iqvia cheaper than Charles River Laboratories International?

On trailing earnings, Iqvia trades at a P/E of 32.3 and Charles River Laboratories International at 367.4, so Iqvia is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Iqvia or Charles River Laboratories International?

Over five years Iqvia grew revenue about 7.5% a year and Charles River Laboratories International about 6.6% a year.

Full Iqvia analysis → Full Charles River Laboratories International analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.